PFBT
DYN icon

Parkside Financial Bank & Trust’s Dyne Therapeutics DYN Stock Holding History

Parkside Financial Bank & Trust’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-70
Closed -$1.37K – 2717
2025
Q4 		$1.37K Buy
70
+30
+75% +$568 ﹤0.01% 2233
2025
Q3 		$506 Sell
40
-10
-20% -$114 ﹤0.01% 2568
2025
Q2 		$476 Sell
50
-30
-38% -$330 ﹤0.01% 2577
2025
Q1 		$837 Buy
+80
New +$1.14K ﹤0.01% 2175

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

Parkside Financial Bank & Trust's DYN Position: Q1 2026 in Review

Parkside Financial Bank & Trust sold out of Dyne Therapeutics (DYN) in Q1 2026, closing a stake of 70 shares — an estimated $1.37K sold.

Parkside Financial Bank & Trust first reported a position in DYN in Q1 2025 and held it in 4 quarters. The position peaked at $1.37K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • Parkside Financial Bank & Trust reported no remaining Dyne Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 70 Dyne Therapeutics shares in Q1 2026, an estimated $1.37K.
  • Parkside Financial Bank & Trust first reported a position in Dyne Therapeutics in Q1 2025 and held it in 4 quarters.
  • Parkside Financial Bank & Trust's Dyne Therapeutics position peaked at $1.37K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.